Pfizer, following last year’s Chantix recall, pulls blood pressure med in Canada on carcinogen fears fkansteiner Wed, 03/02/2022 […]

Sanofi’s net prices keep slipping—despite list price hikes—thanks to billions in rebates kdunleavy Tue, 03/01/2022 – 19:48

BMS, Novartis, Akebia and more face FDA approval decisions soon, with big sales on the line kdunleavy Tue, […]

Novartis sells pair of manufacturing plants as Sandoz strategic review rolls on fkansteiner Wed, 03/02/2022 – 10:25

FDA says no, thank you to Xpovio’s cancer expansion bid, prompting Karyopharm to run new study aliu Wed, […]

In February I discussed the ways in which doctors and other health professionals can, and do, influence UK […]

Current treatments for eating disorders can at best be described as moderately effective,1 indicating a gap in our […]

Discharging people home or into community settings rapidly and safely after a stay in hospital has long been […]

Paul Nurse is no expert, he says. The geneticist and former president of the Royal Society is humble […]

MS patients given boost by results of study into Kesimpta – a self-administered treatment with potential to improve lives